hotspot -WSS

hotspot

author：explore 2025-10-01 04:13:17 - browse：334

IQVIA signage. -- health tech coverage from STAT — Adobe

The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Headspace, Meta partner to launch VR meditation app for Quest

WSS

Criminal prosecution for violating HIPAA: an emerging threat

Cytokinetics CEO stresses company can launch heart drug on its own

The problem with charging patients to message their doctors

With measles on the rise, a personal story of a devastating disease

NEJM study link tiny plastics in blood vessels to heart problems

With psoriasis trial ahead, Alumis raises $259 million

leisure time

hotspot

explore

Wildfire smoke exposes gaps in outdoor worker protections

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Medicare proposal to cover medical devices draws a mixed reaction

Solving academic medical centers' existential crisis

Psychedelics group wrestles with new pharma identity

IVF, abortion rights issues kick off Biden’s State of the Union

How to save PrEP access — and even expand it

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: Live from STAT Breakthrough Summit West

focus

NVIDIA and Google execs on the future of AI and drug discovery

Novo Nordisk obesity pill bests Wegovy in early trial

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

A deep dive into Applied Therapeutics’ data, and questions on Cassava

The Readout: Amylyx, Alumis, and Lundbeck drug updates

It's time to retire 'poor historian' from clinicians' vocabularies

focus

Wikipedia

knowledge

focus